Ukraine fights spreading HIV epidemic

BUCHA, Ukraine (AP) — Andrei Mandrykin, an inmate at Prison No. 85 outside Kiev, has HIV. He looks ghostly and much older than his 35 years. But Mandrykin is better off than tens of thousands of his countrymen, because is he receiving treatment amid what the World Health Organization says is the worst AIDS epidemic in Europe.
Ahead of World AIDS Day on Saturday, international organizations have urged the Ukrainian government to increase funding for treatment and do more to prevent HIV from spreading from high-risk groups into the mainstream population, where it is even harder to manage and control.
An estimated 230,000 Ukrainians, or about 0.8 percent of people aged 15 to 49, are living with HIV, the virus that causes AIDS. Some 120,000 are in urgent need of anti-retroviral therapy, which can greatly prolong and improve the quality of their lives. But due to a lack of funds, fewer than a quarter are receiving the drugs — one of the lowest levels in the world.
Ukraine's AIDS epidemic is still concentrated among high-risk groups such as intravenous drug users, sex workers, homosexuals and prisoners. But nearly half of new cases registered last year were traced to unprotected heterosexual contact.
"Slowly but surely the epidemic is moving from the most-at-risk, vulnerable population to the general population," said Nicolas Cantau of The Global Fund to Fight AIDS, Tuberculosis and Malaria, who manages work in Eastern Europe and Central Asia. "For the moment there is not enough treatment in Ukraine."
Stigma is also a big problem for those with HIV in Ukraine. Liliya, a 65-year-old woman who would give only her first name, recently attended a class on how to tell her 9-year-old great-granddaughter that she has HIV. The girl, who contacted HIV at birth from her drug-abusing mother, has been denied a place in preschool because of her diagnosis.
"People are like wolves, they don't understand," said Liliya. "If any of the parents found out, they would eat the child alive."
While the AIDS epidemic has plateaued elsewhere in the world, it is still progressing in Eastern Europe and Central Asia, according to Cantau. Nearly 21,200 new cases were reported in Ukraine in 2011, the highest number since the former Soviet republic registered its first case in 1987, and a 3 percent increase over 2010. As a result of limited and often delayed treatment, the number of AIDS-related deaths grew 17 percent last year to about 3,800.
Two years ago, Mandrykin, the prisoner, was on the verge of becoming part of that statistic, with his level of crucial CD4 immune cells — a way to measure the strength of the immune system — dropping to 11. In a healthy person, the CD4 count is usually over 600.
"I was lying in the hospital, I was dying," said Mandrykin, who is serving seven years for robbery, his fourth stint in jail. "It's a scary disease."
After two years of treatment in a small prison clinic, his CD4 count has risen to 159 and he feels much better, although he looks exhausted and is still too weak to work in the workshop of the medium-security prison.
The Ukrainian government currently focuses on testing and treating standard cases among the general population. The anti-retroviral treatment of more than 1,000 inmates, as well as some 10,000 HIV patients across Ukraine who also require treatment for tuberculosis and other complications and all prevention and support activities, are paid for by foreign donors, mainly the Global Fund.
The Global Fund is committed to spending $640 million through 2016 to fight AIDS and tuberculosis in Ukraine and then hopes to hand over most of its programs to the Ukrainian government.
Advocacy groups charge that corruption and indifference by government officials help fuel the epidemic.
During the past two years, Ukrainian authorities have seized vital AIDS drugs at the border due to technicalities, sent prosecutors to investigate AIDS support groups sponsored by the Global Fund and harassed patients on methadone substitution therapy, prompting the Global Fund to threaten to freeze its prevention grant.
Most recently, Ukraine's parliament gave initial approval to a bill that would impose jail terms of up to five years for any positive public depiction of homosexuality. Western organizations say it would make the work of AIDS prevention organizations that distribute condoms and teach safe homosexual sex illegal and further fuel the epidemic. It is unclear when the bill will come up for a final vote.
AIDS drug procurement is another headache, with Ukrainian health authorities greatly overpaying for AIDS drugs. Advocacy groups accuse health officials of embezzling funds by purchasing drugs at inflated prices and then pocketing kickbacks.
Officials deny those allegations, saying their tender procedures are transparent.
Much also remains to be done in Ukraine to educate people about AIDS.
Oksana Golubova, a 40-year-old former drug user, infected her daughter, now 8, with HIV and lost her first husband to AIDS. But she still has unprotected sex with her new husband, saying his health is in God's hands.
Read More..

Awareness of HIV Risk Has Dropped Among Gay Men Even As Infection Rates Rise

More than 30 years after the dawn of the HIV epidemic, the significance of the infection and awareness for how it's transmitted has dropped precipitously among young people, especially among gay men, according to new data from the federal government.
National statistics for 2010 show that more than one-quarter of all new HIV infections are among youths ages 13 to 24. Of the estimated 47,500 new infections in 2010, more than 83% are among men.
Almost three-quarters are attributed to sex between men, and half of all new cases are among African Americans, according to data from the Centers for Disease Control and Statistics.
HIV prevalence among blacks is nearly three times higher than among Hispanics and nearly eight times higher than among whites. Men who have sex with men have prevalence rates nearly 40 times higher than other men,  the authors said.
MORE: HIV Vaccine Under Study May Last a Lifetime
An estimated half of HIV-positive young people are unaware they were infected. The study found that HIV testing was low -- only 12.9 percent among high school students and 34.5 percent among people ages 18 to 24. Testing is less common among males compared to females and is lower among whites and Hispanics compared to African Americans.
"More effort is needed to provide effective school- and community-based interventions to ensure all youths, particularly men who have sex with men, have the knowledge, skills, resources, and support necessary to avoid HIV infection," wrote the authors of the report.
The statistics  are sobering news as World AIDS Day approaches on Dec. 1.
"I think the statistics are alarming and that we should be alarmed," Chris Collins, vice president and director of public policy at amFAR, The Foundation for AIDS Research, told Take Part. "I think that what we in the gay community need to come to grips with is HIV remains our number-one health equity issue. "
MORE: Can HIV Prevention Be Found in a Pill?
In an essay published earlier this month on the amFar web site, Collins and co-author Jeffrey Levi said it's time to refocus the HIV-prevention campaign among gay men. Young men who have sex with men represent the only group in which HIV incidence appears to be increasing, he says.
The alarming HIV incidence among gay men stands in contrast to the popular perception that the HIV threat is under control. Efforts by the LGBT community in the '80s and '90s resulted in an estimated 89 percent decline in HIV transmission over that time period, Collins says.
"I think the advent of life-saving AIDS drugs in the mid '90s was both a wonderful thing that saved the lives of so many gay people but also meant that the gay community, to some degree, turned to many other challenges -- understandably so," he says.
MORE: More People Than Ever Living with HIV
Since then, efforts to educate a new generation of young people about HIV prevention have faded. The LGBT community is needed to reinforce the HIV prevention message, he says.
"We saw the power of the gay community in the '80 and '90s to confront this epidemic and mobilize the public and private sectors to address a problem that was devastating us," Collins says. "We need to reconnect with our activism and focus from the 1980s and help everyone in the gay community get tested and get access to the care they need."
AmFar recently published a brief, "Ending the HIV Epidemic Among Gay Men in the United States" that serves as an agenda for progress. The brief calls for utilizing the Affordable Care Act to improve HIV testing and treatment as well as to promote overall better health among LGBT people.
Stigma is another big reason why people with HIV or who are at higher risk for the infection don't get the healthcare they need, Collins adds.
MORE: FDA Approves Truvada as First HIV Prevention Drug
"We know for sure is stigma is a huge part of the HIV epidemic in the United States," he says. "It impedes people from learning their HIV status, getting the care they need and talking to their doctors openly."
The U.S. Preventive Services Task Force, which advises the federal government on health policy, earlier this month issued preliminary guidelines calling for routine HIV screening as part of a check-up.  In 2006, the CDC recommended that doctors routinely test all patients for HIV, regardless of risk,  however only people at increased risk for HIV were eligible for free HIV screening. The USPSTF recommendation would mean more people could be tested without having a co-pay.
The task force also recommended that people at high risk for infection be tested at least once a year.
"The recommendation from the commission is a hopeful sign and the kind of thing we need to encourage health providers to offer testing," Collins says. "We need to have HIV testing readily accessible and routine in all kinds of environments. It ought to be something doctors and nurses regularly offer. For gay men, they ought to be getting HIV tests regularly, not just every couple of years but perhaps every six months."
MORE: Transgender Healthcare: A Work in Progress
Collins says he expects HIV prevention will re-emerge as a top priority in the LGBT community. The topic will be prominent at the 25th National Conference on LGBT Equality: Creating Change, in January in Atlanta.
"There are a variety of efforts going on to engage the gay community," he says. "I think we're going in the right direction.
Read More..

Health officials: Athens has spiraling HIV crisis

ATHENS, Greece (AP) — Athens is seeing an alarming increase in new HIV infections, particularly among intravenous drug users, health officials warned Friday, as Greece struggles through a protracted financial crisis in which funding for health care and drug treatment programs has been slashed.
While there were about 10-14 new HIV infections per year among Athens drug users from 2008 to 2010, that number shot up to 206 new cases last year and 487 new cases by October this year — a 15-fold and 35-fold increase, respectively, officials said.
"There is no doubt we have a big and rapidly developing epidemic in Athens," Athens University epidemiology and preventive medicine professor Angelos Hatzakis said.
A total of 1,049 new cases of HIV infection were recorded in Greece in the first 10 months of this year, including the 487 drug users. Of the others, 256 were gay men, while 108 caught the virus through heterosexual intercourse, the figures showed.
"One of the reasons is the financial crisis," European Center for Disease Prevention and Control director Marc Sprenger said. "There are more people who are vulnerable, marginalized" and who use drugs.
They turn to cheaper drugs and turn to injecting instead of smoking in order to get the same high from a smaller quantity, officials said.
"We are very concerned," Sprenger said. "What we see now is this increase, and if you don't really pay attention to this, it will become in the future a really huge burden."
Greece has been hammered by a financial crisis since late 2009 that has left the country facing a sixth year of a deep recession and with a quarter of the workforce unemployed. The country relies on international rescue loans from other European countries that also use the euro and the International Monetary Fund to stay solvent.
But in return, the Greek government has imposed several rounds of spending cuts and tax hikes in an effort to reform its economy and reduce its mountainous debt. The cuts have affected health care spending, with many hospitals reporting shortages of basic material, while charities dealing with drug users and HIV sufferers have also struggled to find funds.
One of the main methods of prevention for the spread of the virus among drug users is the distribution of free, clean needles, officials said, and Greek programs have managed to increase the number of needles they hand out from 40 to about 50-60 per addict per year. But the actual number needed in order for the programs to be effective, ECDC officials said, is about 200 for each drug user per year.
"The cost of prevention to avoid HIV infection is significantly lower than that of treating those who become infected," Sprenger said.
Read More..

Zurich puts Sandy storm damage claims at $700 million

 Natural gas distributor Laclede Group Inc is buying two utilities from Energy Transfer Equity LP for $1 billion, doubling its customer numbers and boosting its exposure to more stable state-regulated income.
More than 91 percent of Laclede's earnings will come from rate-regulated business after the acquisition of Missouri Gas Energy and New England Gas Co, owned by Energy Transfer's affiliate, Southern Union Co.
About 68 percent of Laclede's operating revenue of $1.12 billion came from its regulated gas distribution business in the year ended September 30.
"With lower ... prices, more and more customers are interested in using natural gas," Chief Executive Suzanne Sitherwood told Reuters. "The other emerging market that is taking place is with natural gas vehicles."
Gas prices have fallen sharply from their peak of more than $13 per million metric British thermal unit (mmBtu) to about $3 now due to vast supplies from shale fields in North America.
This has prompted increased use of gas for heating and power generation. Westport Innovations Inc , General Motors Co , Caterpillar Inc and Ford Motor Co are some of the companies developing technologies to drive the use of the fuel in vehicles.
Laclede too has been working on fueling natural gas vehicles and has received a lot of interest for possible partnerships, Sitherwood said. She did not name the interested parties.
GOOD PRICE FOR ETE
Missouri Gas and New England Gas, which had combined revenue of about $517 million for the year ended September 30, serve more than 500,000 customers in western Missouri and about 50,000 in Massachusetts.
The acquisition, which includes debt of about $20 million, will take Laclede's customer base to 1.2 million, the company said in a statement.
Laclede expects the acquisition to be neutral to its earnings per share in the first full year after close, likely in the third quarter of 2013.
Energy Transfer Partners LP , a unit of Energy Transfer Equity and a party to the deal, said the transaction was part of the company's efforts to divest non-core assets.
The gas utilities passed into Energy Transfer's hands when it bought pipeline operator Southern Union Co last year.
"For the Energy Transfer family, this (deal) compares favorably to our previously modeled $710 million sale estimate," analysts at Robert W. Baird wrote in a note to clients.
St Louis, Missouri-based Laclede said Wells Fargo Bank will provide a $1 billion bridge facility for the purchase.
Laclede shares were down about 2 percent at $39.12 in afternoon trading on Monday on the New York Stock Exchange. Shares of Energy Transfer Equity and Energy Transfer Partners were slightly up.
Wells Fargo Securities LLC advises Laclede, while Credit Suisse Securities LLC is advising Energy Transfer and Southern Union. Moelis & Co gave the fairness opinion to Laclede.
Read More..

Laclede to double customers in $1 billion deal with Energy Transfer

 Natural gas distributor Laclede Group Inc is buying two utilities from Energy Transfer Equity LP for $1 billion, doubling its customer numbers and boosting its exposure to more stable state-regulated income.
More than 91 percent of Laclede's earnings will come from rate-regulated business after the acquisition of Missouri Gas Energy and New England Gas Co, owned by Energy Transfer's affiliate, Southern Union Co.
About 68 percent of Laclede's operating revenue of $1.12 billion came from its regulated gas distribution business in the year ended September 30.
"With lower ... prices, more and more customers are interested in using natural gas," Chief Executive Suzanne Sitherwood told Reuters. "The other emerging market that is taking place is with natural gas vehicles."
Gas prices have fallen sharply from their peak of more than $13 per million metric British thermal unit (mmBtu) to about $3 now due to vast supplies from shale fields in North America.
This has prompted increased use of gas for heating and power generation. Westport Innovations Inc , General Motors Co , Caterpillar Inc and Ford Motor Co are some of the companies developing technologies to drive the use of the fuel in vehicles.
Laclede too has been working on fueling natural gas vehicles and has received a lot of interest for possible partnerships, Sitherwood said. She did not name the interested parties.
GOOD PRICE FOR ETE
Missouri Gas and New England Gas, which had combined revenue of about $517 million for the year ended September 30, serve more than 500,000 customers in western Missouri and about 50,000 in Massachusetts.
The acquisition, which includes debt of about $20 million, will take Laclede's customer base to 1.2 million, the company said in a statement.
Laclede expects the acquisition to be neutral to its earnings per share in the first full year after close, likely in the third quarter of 2013.
Energy Transfer Partners LP , a unit of Energy Transfer Equity and a party to the deal, said the transaction was part of the company's efforts to divest non-core assets.
The gas utilities passed into Energy Transfer's hands when it bought pipeline operator Southern Union Co last year.
"For the Energy Transfer family, this (deal) compares favorably to our previously modeled $710 million sale estimate," analysts at Robert W. Baird wrote in a note to clients.
St Louis, Missouri-based Laclede said Wells Fargo Bank will provide a $1 billion bridge facility for the purchase.
Laclede shares were down about 2 percent at $39.12 in afternoon trading on Monday on the New York Stock Exchange. Shares of Energy Transfer Equity and Energy Transfer Partners were slightly up.
Wells Fargo Securities LLC advises Laclede, while Credit Suisse Securities LLC is advising Energy Transfer and Southern Union. Moelis & Co gave the fairness opinion to Laclede.
Read More..

Sun Life sells U.S. annuity business, shares drop

 Sun Life Financial Inc will sell its U.S. annuity business for $1.35 billion to a firm connected to Guggenheim Partners in a deal that should reduce the exposure of the insurer's earnings to market swings and boost its cash levels.
While the deal could bring long-term benefits to Sun Life, whose earnings have been derailed by wild market swings during recent years, investors pulled the company's shares down by nearly 4 percent as the financial terms fell short of initial expectations.
"The stock's sort of correcting back because the deal isn't quite as big a windfall as I think the market was anticipating," said National Bank financial analyst Peter Routledge.
Delaware Life Holdings, owned by certain Guggenheim clients and shareholders, will rename itself Delaware Life Insurance Co following the cash purchase. Guggenheim will provide investment management services to the new company.
Sun Life, Canada's No. 3 insurer, said last year it would stop selling variable annuities and individual life products in the United States to focus more on group insurance and voluntary benefits.
Variable annuities - retirement products that guarantee the investor a minimum monthly payment - became a source of earnings volatility for Sun Life in the wake of the 2008 financial crisis. That is because low interest rates and Canadian accounting rules force insurers to take upfront losses on products that will not come due for years.
"The business makes money, but not enough," said Routledge.
Weak equity markets and low bond yields sent Sun Life's profit down 87.5 percent during the second quarter of 2012 and caused losses during the third and fourth quarters of 2011.
EARNINGS HIT
The deal will cut Sun Life's profit by 22 Canadian cents a share annually and reduce book value by C$950 million ($965 million), the company said in a statement. According to Thomson Reuters I/B/E/S, Sun Life was expected to earn C$2.53 a share on a net basis in 2013.
The deal has also prompted Sun Life to take a second look at its 2015 financial targets, which include a goal of C$2 billion in operating profit.
In an interview, Sun Life Chief Executive Dean Connor said he would update the market on the targets after the deal closes, which is expected during the second quarter next year.
"I'm not saying we will necessarily reduce them. I'm not saying we will necessarily leave them as they are, because we don't know yet," he said.
The deal is also expected to reduce the company's earnings sensitivity to equity markets by 50 percent and its sensitivity to interest rates by 35 percent, compared with estimates on September 30.
It will raise Sun Life's cash position to C$1.9 billion.
"Over time, we'll redeploy that cash to fund growth," said Connor. He said the growth could include acquisitions on the "smaller end of the spectrum."
Sun Life, which also owns U.S. asset manager MFS Investment Management, is targeting growth in its Asian business.
SHARES DOWN
Sun Life shares, which have outperformed its rivals with a 47 percent year-to-date rise coming into Monday's session, ended down 3.9 percent at C$26.74 on the Toronto Stock Exchange. Despite the strong rise this year, the stock still trades at less than half its all-time high set in 2007.
Robert Sedran, an analyst at CIBC World Markets, said in a research note that the earnings and book value reductions were worse than he had expected.
"Moreover, while the decline in the earnings sensitivity to market variables improves the risk-reward profile, we did not view those sensitivities as excessive to begin with," he said.
However, he said the deal will free up time and capital that would otherwise have been engaged in what is essentially a closed business, which is a positive.
Morgan Stanley & Co advised Sun Life on the transaction financials.
Law firm Debevoise & Plimpton LLP was legal adviser to Sun Life, while Skadden, Arps, Slate, Meagher & Flom advised Guggenheim Partners.
Read More..

FactSet forecasts second-quarter results largely below estimates, shares fall

FactSet Research Systems Inc reported lower-than-expected first-quarter revenue, and the financial information provider forecast current-quarter results largely below estimates as banks and brokerages cut costs.
FactSet shares fell 5 percent before the bell on Tuesday.
The company, which provides data to portfolio managers, research analysts and investment bankers, forecast second-quarter earnings of $1.11 to $1.13 per share, on revenue of $212 million and $215 million.
Analysts on average were expecting earnings of $1.13 per share on revenue of $216.3 million, according to Thomson Reuters I/B/E/S.
FactSet's financial sector clients are cutting staff and trimming costs to cope with increased regulation and a struggling global economy.
In the United States, financial companies have announced plans to cut 28,000 jobs through the first nine months of this year, compared with 54,000 during the same period in 2011, according to executive placement firm Challenger, Gray & Christmas.
FactSet said its net income rose to $49.8 million, or $1.11 per share, in the first quarter, from $45.5 million, or 99 cents per share, a year earlier.
The company earned $1.22 cents per share, excluding items.
Revenue rose 7.5 percent to $211.1 million for the quarter ended November 30.
Analysts on average had expected earnings of $1.11 per share, on revenue of $212.3 million.
FactSet rival Thomson Reuters Corp, the owner of Reuters News, last month reported a 15 percent fall in operating profit for the quarter ended September 30, on declining revenue and higher costs in its division that serves the financial industry.
FactSet's shares closed at $96.39 on the New York Stock Exchange on Monday.
Read More..

Jefferies results beat estimates on higher fixed-income revenue

(Reuters) - Jefferies Group Inc reported a higher-than-expected adjusted quarterly profit as the investment bank benefited from higher earnings from its fixed-income unit, and said its business expansion in Asia has started delivering.
The midsized investment bank has been expanding in China and India and recently poached bankers from the Royal Bank of Scotland to expand its business in China.
Jefferies said it also benefited from a pickup in trading across the board in September thanks to fresh stimulus plans from the U.S. Federal Reserve, and that it was gaining market share from larger rivals. The Fed had unveiled a program to purchase $40 billion in mortgage bonds.
The company saw its trading revenue more than double to $293 million from $141 million a year earlier.
"Our competitive position is very strong so across the products within fixed income I think we're gaining market share," Chief Executive Richard Handler said on a post-earnings conference call.
As the first investment bank to report earnings, Jefferies is often viewed as an indicator for larger Wall Street banks such as Goldman Sachs Group and Morgan Stanley .
Jefferies, founded in 1962 in Los Angeles to trade large stock orders away from the New York Stock Exchange, agreed last month to be bought by top shareholder Leucadia National Corp for $2.76 billion in stock.
"Combining our company with an extremely well-capitalized parent will allow us to continue to aggressively add value to our clients," Jefferies said in a statement on Tuesday.
Compensation costs at the company remained high with the company paying 59.9 percent of net revenue to employees, in line with previous periods but higher than the 50 percent industry peers generally target.
Net income rose to $72 million, or 31 cents per share, in the fourth quarter from $48 million, or 21 cents per share, a year earlier.
On an adjusted basis, earnings were 35 cents per share.
Analysts had expected the company to earn 32 cents per share, according to Thomson Reuters I/B/E/S.
Revenue for the quarter rose 39 percent to $769 million, above estimates of $722.6 million. Investment banking revenue rose 8 percent to $283 million.
Jefferies shares, which have risen 12 percent since the Leucadia deal was announced in mid-November, was trading up 2.5 percent at $18.70 on the New York Stock Exchange on Tuesday.
Read More..

Facebook Shrugs Off Instagram's New Class Action Lawsuit

For Instagram, there's good news and there's bad news about the class action lawsuit just filed against them. Bad news first: Somebody just filed a class action lawsuit. Good news: the lawyers from Instagram's parent company, Facebook, have plenty of practice getting rid of these pesky things. That might explain why they're so dismissive about the legal inconvenience a group of disgruntled Instagram users left under its tree this year. "We believe this complaint is without merit and we will fight it vigorously," says Facebook spokesman Andrew Nusca. It'll obviously take more than the half-hearted apology Instagram CEO and co-founder Kevin Systrom made at the end of last week.
RELATED: It's Time to Accept the Existence of a Social Media Bubble
The lawsuit's complaint is somewhat understandable. If you've so much as heard the word "Instagram" you've heard about how much their new terms of service stink. In it, the company declared that it "may share User Content and your information (including but not limited to, information from cookies, log files, device identifiers, location data, and usage data)" with Facebook, its subsidiaries and its "affiliates." Instagram users understood this to mean that Instagram could sell their photos to advertisers, though Systrom pushed back at that in his blog post when he more or less said that the company would revert to its old terms of service. "We don't own your photos – you do," he said.
RELATED: And the Actual Retail Price for Instagram Is...
Instagram kept three key new details in place, though. One, the company maintained the ability to serve ads in your feed. Two, it said "that we may not always identify paid services, sponsored content, or commercial communications as such." Lastly, it left in place the mandatory arbitration clause that it added with the new terms of service, forcing users to waive their right to participate in class action lawsuit. That obviously didn't discourage this group of plaintiffs who said in the lawsuit that "Instagram declares that 'possession is nine-tenths of the law and if you don't like it, you can't stop us.'"
RELATED: Mark Zuckerberg Disappears from Google+ Due to Privacy Settings
No big deal. Instagram is a part of Facebook now, and Facebook has dealt with class action lawsuits before. Just seven months ago, it got slammed with a $15 billion class action suit from users who said that the social network was "improperly tracking the internet use of its members even after they logged out of their accounts." They haven't settled yet, but if it winds up anything like the class action lawsuit over the Beacon advertising program a few years ago, it could take years to resolve and could cost Facebook millions. With some good lawyering, though, this latest lawsuit won't cost as many millions as it could. But Instagram will never be the same.
Read More..

How 'Doctor Who' Kept Its Big Christmas Secret Off Twitter

Tonight Doctor Who fans get to gorge on their annual Christmas fix -- a full-length special episode the series has produced every year for the holiday since 2005. This time, however, there's some extra spice in the form of a new regular cast member: Jenna-Louise Coleman debuts in "The Snowmen" as the Doctor's next companion.
Except it's not her debut. Coleman actually made her first appearance in the series premiere back in September. Actually, make that surprise appearance. In preseason interviews, Doctor Who's producers had explicitly told fans they'd have to wait until Christmas before they'd see Coleman in the show.
[More from Mashable: Top 10 Twitter Pics of the Week]
But there she was, fighting Daleks and making soufflés, way ahead of schedule. This was unheard of for the series, which has seen major plotlines leak online -- usually months before broadcast -- several times over the past few years. The show had gotten to the point where it would simply announce any major developments far in advance in order to get ahead of the spoiler hunters.
Yet somehow the show's producers kept Coleman's early debut a secret -- a feat made even more challenging since there were several preview screenings of the episode, each attended by hundreds of rabid fans, all carrying smartphones. How did Doctor Who keep every single one of them from tweeting about it?
[More from Mashable: How Music Ruled Twitter in 2012]
"I asked. That's it," says Steven Moffat, Doctor Who's current showrunner. "I don't think anyone thought it would work. I certainly didn't. At the London premiere, I just stood up and said, 'Please, nobody, no fan, no newspaper -- nobody at all -- mention that she's in it. And to my surprise it worked."
SEE ALSO: How 'Doctor Who' Won Over America
Moffat says the idea of misleading the audience about when Coleman would debut "grew" as he was writing the current series. But it almost didn't happen since others at the BBC wanted to get ahead of the news and announce her presence at the first preview screening. Moffat, however, was convinced (rightly, it turns out) that he could persuade the fans and journalists in attendance to guard the secret.
"They tried to talk me out of it at the last minute," he says. "And it did involve a lot of charming journalists and saying 'Please don't...' It was the polite embargo, really. We couldn't really embargo it. And I was always clear, 'There is no punishment here. You don't get blacklisted -- I'm just asking, and the show will be better if you keep this secret.' And they did."
But did really not a single person on fire off a quick tweet about Coleman being on the show? It appears so. Although Twitter doesn't offer a way to search tweets within a specific date range, searching the Twitter domain on Google during the month of August (the series premiered on Sept. 1) for her name reveals just regular promotion for the show.
"You can get a long way just by asking politely," says Moffat. "Who knew that's all you had to do? What's remarkable about it is not one single person broke. And I really didn't think that was going to work, because if any website had broken it -- if any forum had broken it -- the press would have just leapt in. They would have felt no further need for restraint. But they didn't."
Now Coleman makes her "proper" debut in the Christmas special, but is she playing the same character as before (who was -- spoiler alert -- abruptly killed off), or someone different? Moffat's already told fans not to expect any great explanations under the tree. What's going on with Coleman's character (characters?) won't be fully revealed until the series returns in the New Year.
But who knows? Maybe that's another mislead.
Will you be watching Doctor Who tonight? Does the show still surprise you? Share your thoughts in the comments.
BONUS: Doctor Who Series 7 Premiere
Doctor Who Returns
Matt Smith (The Doctor) and Karen Gillan (Amy Pond) attended a special screening of the premiere of Doctor Who Series 7 at New York City's Ziegfeld Theater. The episode, "Asylum of the Daleks," debuts on BBC America on Sept. 1.
Read More..